Deans' stroke musings: Trends and Disparities in Poststroke Depression Within 1 Year of Ischemic Stroke

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, September 25, 2025

Trends and Disparities in Poststroke Depression Within 1 Year of Ischemic Stroke

You're that blitheringly stupid you don't know that this DOES NOTHING TO GET SURVIVORS RECOVERED?

Trends and Disparities in Poststroke Depression Within 1 Year of Ischemic Stroke

Maria X.Sanmartin Ph.D. https://orcid.org/0000-0001-7227-8827 msanmartin@northwell.edu Jeffrey M. Katz M.D. Mir M.AliPh.D. Jason J.Wang Ph.D. Elizabeth G. Cohn R.N., Ph.D. Elizabeth Rula Ph.D. Liron D. Sinvani Pina C. Sanelli M.D., M.P.H. AUTHORS INFO & AFFILIATIONS Publication The Journal of Neuropsychiatry and Clinical Neurosciences In Advance https://doi.org/10.1176/appi.neuropsych.20240247 Information & Authors

Abstract

Objective:

One of the most frequent neuropsychiatric complications after a stroke is poststroke depression (PSD). However, it is unclear whether disparities exist in PSD diagnosis. The authors examined a 10-year trend in PSD by socioeconomic and clinical characteristics.

Methods:

A retrospective cohort study of acute ischemic stroke (AIS) patients admitted to a stroke network in 2014–2023 was performed. PSD was defined as newly diagnosed major depression or initiation of antidepressant medication up to 1 year poststroke. Trend, bivariate, and multivariable logistic regression analyses of patient sociodemographic and clinical characteristics and discharge stroke outcomes were conducted.

Results:

Of 23,514 AIS patients, 15.0% (N=3,534) met the criteria for PSD. Women and non-Hispanic Whites were diagnosed as having PSD at a higher proportion than were men and non-White patients, respectively. Higher odds of PSD were associated with female sex (OR=1.32, 95% CI=1.22–1.43), ages 18–49 years (OR=1.30, 95% CI=1.08–1.56) and 50–79 years (OR=1.26, 95% CI=1.15–1.38), National Institutes of Health Stroke Scale score of 6–15 at hospital admission (OR=1.23, 95% CI=1.10–1.37), and modified Rankin Scale score of 2–3 at hospital discharge (OR=1.32, 95% CI=1.19–1.46) and 4–5 (OR=1.38, 95% CI=1.24–1.53).

Conclusions:

Women, non-Hispanic White patients, and middle-aged patients and patients with moderate stroke severity on initial examination and poor functional outcomes at discharge were more likely to have a PSD diagnosis. Long-term depression screening is a pressing need among stroke patients, especially among racial-ethnic minority populations that may be underdiagnosed or undertreated for PSD.